Skip Navigation


Rheumatology Advance Access originally published online on June 9, 2009
Rheumatology 2009 48(10):1197-1201; doi:10.1093/rheumatology/kep130
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/10/1197    most recent
kep130v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Závada, J.
Right arrow Articles by Tesar, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Závada, J.
Right arrow Articles by Tesar, V.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis

Jakub Závada1,2, Lindy Kideryová3, Robert Pytlík3, Zdenka Hrusková1 and Vladimír Tesar1

1Department of Nephrology, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital,2Institute of Rheumatology and 3First Department of Internal Medicine and Haematooncology, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic.

Correspondence to: Jakub Závada, Institute of Rheumatology, Na Slupi 4, 128 50, Praha 2, Czech Republic. E-mail: zavada{at}revma.cz


  Abstract

Objectives. ANCA-associated vasculitis (AAV) is an inflammatory disorder of small- to medium-sized vessels with relapsing/remitting progression. Microvascular endothelial injury is a major feature of AAV. Circulating endothelial progenitor cells (EPCs) may provide an endogenous repair mechanism to counteract ongoing endothelial damage. We hypothesized that decreased capacity for endothelial regeneration paralleled by low EPC numbers could increase the risk of relapse in patients with AAV.

Methods. The number of circulating EPCs was determined by a colony-forming assay in a cohort of 41 patients with AAV. The patients were stratified into three subgroups according to the initial EPC count (low, medium and high) and prospectively followed. The primary goal was to determine the association between baseline EPC level and the time to the first relapse of the disease.

Results. A total of 19 (46%) patients relapsed during the study period. The cumulative relapse-free survival increased stepwise across three increasing baseline levels of EPCs (P = 0.013). EPC levels were not predictive of progression of renal disease, number of organs involved or death from any cause.

Conclusion. Low numbers of EPCs are associated with increased propensity for early relapse of AAV.

KEY WORDS: Vasculitis, Anti-neutrophil cytoplasmic antibody, Relapse, Outcome, Endothelial progenitor cell, Endothelium, Pauci-immune glomerulonephritis, Wegener's granulomatosis

Submitted 12 January 2009; revised version accepted 21 April 2009.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
A. N. C. Santana
Circulating endothelial progenitor cells in ANCA-associated vasculitis: the light at the end of the tunnel?
Rheumatology, October 1, 2009; 48(10): 1183 - 1184.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.